RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Today's meeting.Well, with all due respect, "pros" like yourself have been professing great buying opportunities since the stock has started dropping after it became clear that BioCloud implied projections were entirely unrealistic and unachievable. I recall may fans and pumpers professing great opportunities to average down in the $2s, high $1s, mid-$1s etc. Given where the share price is now, it is pretty easy to conclude that all those calls were wrong and folk would have lost more money. You are now singing the same tune suggesting that this is a must buy. I had averaged down, hold more than enough shares, and with the markets tanking and what KNR has or has not done, my money may just find better opportunities, either much greater returns albeit at a higher risk I am willing to accept or lower returns but at lower risks.
I will now go back to a couple of other points I let fly by.
Fundamentally, market cap versus revenues, is but one of many metrics to assess the attractiveness of the share price. And it is the most basic one, and the easiest one, and the most meaningless ones....because cash pays bills, not revenues. You may recall that KNR paid under $10 million for acquisition of Global which at the time sounded to have had a multi-year contractual backlog of over $100 million. You seem to suggest that the owners of Global were such poor business folk that they left easy millions on the table. But even PG will tell you that is not so by telling you that he seeks out acquisitions based on EBITDA valuation. Comparing the market cap to revenues is amateur. It is not impossible to find micro caps now where their market caps are lesser than their revenues.
As you know, many stock forums claim how their depressed stocks are manipulated by shorters and organized groups. The most likely fact of the matter is that algos are out there used to take advantage of the system that allows them to do so, and they can depress prices.....just like they could pump them up (something that nobody seems to complain about). PG took us to a "senior exchange" to diminish some of this impact. How is that working out? I believe the idea of taking the company to a senior exchange is to allow institutional investment that has policies prohibiting them from purchasing equities on venture type exchanges where the more risky stuff is allowed to list. I have not seen anything since the listing on NEO that suggests that we had some meaningful institutional investment into KNR, which would place more of a float into stronger hands. You could ask yourself why full time "professionals" are missing newsreleases of a company that is growing as fast as KNR.
I am good with not gambling with my money on this one anymore. I thought I was not gambling on BioCloud and since that turned out to be a collossal losing gamble, the attractiveness of KNR even with phenomenal traditional product performance is NOTHING compared to what it would have been had they been able to sell 10% of what they strongly suggested they would be selling. Many other plays out there with a potential for a double or a triple or more, so with new money I would rather give a chance to companies that are more transparent with their shareholders. You will not be selling me your shares at higher prices. ;-)
overroad wrote: Mostlyserious wrote: Urgh. A promising start with a foundation for an intelligent discussion, but followed by a significant deterioration not worthy the effort on the first part. I could plead to being a dissatisfied investor with the company's communication. With respect to virginity, let's call it a private matter that is not relevant to this investment.
with all due respect, ( and ya'll barely deserve that) i lf you even agree with half of the first part amd youre not buying more at these prices, you are not investing correctly. buy when others are fearful. your constant drivelling has me even more confident that this is the time to buy. ill sell you my shares after it pops amd you buy into the hype. amateurs.